266 related articles for article (PubMed ID: 17188851)
1. An investigation into the usefulness of generalized regression neural network analysis in the development of level A in vitro-in vivo correlation.
Parojcić J; Ibrić S; Djurić Z; Jovanović M; Corrigan OI
Eur J Pharm Sci; 2007 Mar; 30(3-4):264-72. PubMed ID: 17188851
[TBL] [Abstract][Full Text] [Related]
2. Influence of dissolution media composition on drug release and in-vitro/in-vivo correlation for paracetamol matrix tablets prepared with novel carbomer polymers.
Parojcić J; Ethurić Z; Jovanović M; Ibrić S; Jovanović D
J Pharm Pharmacol; 2004 Jun; 56(6):735-41. PubMed ID: 15231038
[TBL] [Abstract][Full Text] [Related]
3. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
Cao QR; Choi YW; Cui JH; Lee BJ
J Control Release; 2005 Nov; 108(2-3):351-61. PubMed ID: 16154656
[TBL] [Abstract][Full Text] [Related]
4. Optimization of drug release from compressed multi unit particle system (MUPS) using generalized regression neural network (GRNN).
Ivic B; Ibric S; Betz G; Zorica D
Arch Pharm Res; 2010 Jan; 33(1):103-13. PubMed ID: 20191351
[TBL] [Abstract][Full Text] [Related]
5. Generalized regression neural networks in prediction of drug stability.
Ibrić S; Jovanović M; Djurić Z; Parojcić J; Solomun L; Lucić B
J Pharm Pharmacol; 2007 May; 59(5):745-50. PubMed ID: 17524242
[TBL] [Abstract][Full Text] [Related]
6. A new approach to modelling the relationship between in vitro and in vivo drug dissolution/absorption.
Dunne A; O'Hara T; Devane J
Stat Med; 1999 Jul; 18(14):1865-76; discussion 1877. PubMed ID: 10407257
[TBL] [Abstract][Full Text] [Related]
7. High-amylose carboxymethyl starch matrices for oral sustained drug-release: in vitro and in vivo evaluation.
Nabais T; Brouillet F; Kyriacos S; Mroueh M; Amores da Silva P; Bataille B; Chebli C; Cartilier L
Eur J Pharm Biopharm; 2007 Mar; 65(3):371-8. PubMed ID: 17275270
[TBL] [Abstract][Full Text] [Related]
8. In vitro - in vivo correlation: from theory to applications.
Emami J
J Pharm Pharm Sci; 2006; 9(2):169-89. PubMed ID: 16959187
[TBL] [Abstract][Full Text] [Related]
9. Critical dissolution tests of oral systems based on statistically designed experiments. III. In vitro/in vivo correlation for multiple-unit capsules of paracetamol based on PLS modeling.
Abuzarur-Aloul R; Gjellan K; Sjölund M; Graffner C
Drug Dev Ind Pharm; 1998 Apr; 24(4):371-83. PubMed ID: 9876598
[TBL] [Abstract][Full Text] [Related]
10. In vitro-in vivo correlation for nevirapine extended release tablets.
Macha S; Yong CL; Darrington T; Davis MS; MacGregor TR; Castles M; Krill SL
Biopharm Drug Dispos; 2009 Dec; 30(9):542-50. PubMed ID: 19876936
[TBL] [Abstract][Full Text] [Related]
11. Tablet disintegration and drug dissolution in viscous media: paracetamol IR tablets.
Parojcić J; Vasiljević D; Ibrić S; Djurić Z
Int J Pharm; 2008 May; 355(1-2):93-9. PubMed ID: 18226480
[TBL] [Abstract][Full Text] [Related]
12. In vitro-in vivo correlations of self-emulsifying drug delivery systems combining the dynamic lipolysis model and neuro-fuzzy networks.
Fatouros DG; Nielsen FS; Douroumis D; Hadjileontiadis LJ; Mullertz A
Eur J Pharm Biopharm; 2008 Aug; 69(3):887-98. PubMed ID: 18367386
[TBL] [Abstract][Full Text] [Related]
13. A level A in vitro/in vivo correlation in fasted and fed states using different methods: applied to solid immediate release oral dosage form.
Souliman S; Blanquet S; Beyssac E; Cardot JM
Eur J Pharm Sci; 2006 Jan; 27(1):72-9. PubMed ID: 16169713
[TBL] [Abstract][Full Text] [Related]
14. In-vitro and in-vivo correlation for two gliclazide extended-release tablets.
Mandal U; Ray KK; Gowda V; Ghosh A; Pal TK
J Pharm Pharmacol; 2007 Jul; 59(7):971-6. PubMed ID: 17637192
[TBL] [Abstract][Full Text] [Related]
15. Development and biopharmaceutical evaluation of extended release formulation of tramadol hydrochloride based on osmotic technology.
Kumar P; Singh S; Mishra B
Acta Pharm; 2009 Mar; 59(1):15-30. PubMed ID: 19304555
[TBL] [Abstract][Full Text] [Related]
16. In vitro--in silico--in vivo drug absorption model development based on mechanistic gastrointestinal simulation and artificial neural networks: nifedipine osmotic release tablets case study.
Ilić M; Ðuriš J; Kovačević I; Ibrić S; Parojčić J
Eur J Pharm Sci; 2014 Oct; 62():212-8. PubMed ID: 24911992
[TBL] [Abstract][Full Text] [Related]
17. Artificial neural network for the joint modelling of discrete cause-specific hazards.
Biganzoli EM; Boracchi P; Ambrogi F; Marubini E
Artif Intell Med; 2006 Jun; 37(2):119-30. PubMed ID: 16730963
[TBL] [Abstract][Full Text] [Related]
18. Comparison of artificial neural network and multiple linear regression in the optimization of formulation parameters of leuprolide acetate loaded liposomes.
Arulsudar N; Subramanian N; Muthy RS
J Pharm Pharm Sci; 2005 Aug; 8(2):243-58. PubMed ID: 16124936
[TBL] [Abstract][Full Text] [Related]
19. Pharmaceutical granulation and tablet formulation using neural networks.
Kesavan JG; Peck GE
Pharm Dev Technol; 1996 Dec; 1(4):391-404. PubMed ID: 9552323
[TBL] [Abstract][Full Text] [Related]
20. Selection of the most suitable dissolution method for an extended release formulation based on IVIVC level A obtained on cynomolgus monkey.
Scheubel E; Adamy L; Hoffart V; Cardot JM
Drug Dev Ind Pharm; 2010 Nov; 36(11):1320-9. PubMed ID: 20849348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
